Needham & Company analyst Elliot Wilbur trimmed his price target on Pernix Therapeutics (NASDAQ: PTX) from $6 to $5 but ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE